C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
07/2003
07/15/2003	US6593360 The invention relates to novel 15-membered 8a- and 9a-lactams from the class of 6-O-methyl-erythromycin A of general formula their pharmaceutically acceptable addition salts with inorganic or organic acids and their hydrates, to
07/02/2003	EP1175429B1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
06/2003
06/19/2003	US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/18/2003	EP1077984B1 2"-deoxy hygromycin derivatives
06/12/2003	US20030108923 Blocking gene expression
06/05/2003	WO2003045968A1 3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
05/2003
05/29/2003	US20030100518 13-Methyl erythromycin derivatives
05/21/2003	EP1091970B1 Method for preparing aloin by extraction
05/21/2003	EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003	CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/15/2003	WO2003040162A1 Method for the production of desclarithromycin, and intermediate products
05/15/2003	WO2003039404A2 Methods for treating ocular neovascular diseases
05/15/2003	CA2464007A1 Methods for treating ocular neovascular diseases
05/14/2003	EP1309726A2 Rna sequence-specific mediators of rna interference
05/13/2003	US6562792 Hygromycin derivatives
05/08/2003	US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
05/02/2003	EP0837871B1 Magnetic pigment
04/2003
04/23/2003	EP1175428B1 3-deoxy-desmycosin derivatives and process for their preparation
04/23/2003	CN1106401C 磁性色素 Magnetic pigment
04/15/2003	US6548484 An amidation product of ribosyl or glucosyl saccharide and a dopamine or derivative ( forms a amide through amine and carboxylic group); useful for treating neurological diseases including Parkinson's and related diseases
04/03/2003	WO2002024909A9 Receptor nucleic acids and polypeptides
03/2003
03/27/2003	US20030060476 Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration
03/27/2003	US20030060400 A modified nucleoside comprising a purine or pyrimidine ring for treating viral infections
03/26/2003	EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses
03/26/2003	CN1405127A Nitrogenous group conversion method
03/19/2003	EP1292604A1 2-aminocarbonyl-9h-purine derivatives
02/2003
02/27/2003	WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
02/27/2003	WO2001075164A3 Rna sequence-specific mediators of rna interference
02/27/2003	CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
02/20/2003	WO2002103060A9 Enterovirus nucleic acids and methods for detecting enterovirus
02/05/2003	EP1281714A1 Magnetic pigment
02/05/2003	EP1280535A1 Processes for preparing clarithromycin polymorphs
02/04/2003	CA2112818C Mono and bis alkylamino-anthracyclines
01/2003
01/16/2003	CA2785699A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
01/14/2003	US6506387 Method for preparing aloin by extraction
01/07/2003	US6504035 3-deoxy-desmycosin derivatives and process for their preparation
01/07/2003	CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections
01/02/2003	EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
01/02/2003	EP1267892A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
12/2002
12/27/2002	WO2002103060A2 Enterovirus nucleic acids and methods for detecting enterovirus
12/27/2002	WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002	CA2451524A1 Templated molecules and methods for using such molecules
12/17/2002	US6495528 Antiinflammatory agents; inhibiting leukocyte recruitment and activation; agonists of adenosine 2a receptor
12/10/2002	US6492342 Hygromycin A prodrugs
11/2002
11/27/2002	CN1382150A Hydromycin derivatives
11/27/2002	CN1382149A Hygromycin A prodrugs
11/26/2002	CA2067184C New linker for bioactive agents
11/14/2002	US20020168427 Plant extract
11/07/2002	WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002	CA2594883A1 Pharmaceutically active uridine esters
11/07/2002	CA2445861A1 Pharmaceutically active uridine esters
10/2002
10/29/2002	CA2014486C Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyltrithio group
10/16/2002	CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/10/2002	WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/10/2002	US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/01/2002	CA1341389C Human granulocyte colony stimulating factor
09/2002
09/26/2002	WO2002057414A3 Leukocyte expression profiling
09/26/2002	US20020137920 Magnetic pigment
09/24/2002	US6455507 Benzimidazole derivatives
09/18/2002	EP1239864A1 Treatment of heart rhythm disturbances with n6 -substituted-5'-(n-substituted) carboxamidoadenosines
09/04/2002	EP0205475B2 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
08/2002
08/21/2002	CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages
08/13/2002	US6432682 Substances KF-1040 and process for producing of the same
08/07/2002	CN1362964A Novel 8A-and 9A-15-membered lactams
08/07/2002	CN1362963A 3-deoxy-desmycosin derivatives and process for their preparation
07/2002
07/25/2002	WO2002057425A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/25/2002	WO2002057414A2 Leukocyte expression profiling
07/25/2002	WO2002057287A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/25/2002	CA2426540A1 Leukocyte expression profiling
07/24/2002	EP1224197A1 Hygromycin derivatives
07/24/2002	EP1224194A1 Hygromycin a prodrugs
07/18/2002	US20020094963 Benzimidazole derivatives
07/17/2002	EP1222927A2 Pharmaceutical compositions having appetite suppressant activity
07/04/2002	US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy
07/03/2002	CN1357002A Compositions for treating inflammatory response
06/2002
06/13/2002	WO2001094362A3 Haplotypes of the acp2 gene
06/12/2002	EP1213020A2 Pharmaceutical compositions having appetite suppressant activity
06/06/2002	WO2002044321A2 Rna interference mediating small rna molecules
06/06/2002	CA2791831A1 Rna interference mediating small rna molecules
06/06/2002	CA2429814A1 Rna interference mediating small rna molecules
05/2002
05/29/2002	CN1351608A B-methyl-erythromycin derivatives
05/29/2002	CN1351606A Halo derivatives of 9-Deoxo-9a-Aza-9a-Homery theromycin A
05/16/2002	US20020058670 Glycosylating purine or pyrimidine base low temperature with an intermediate to for producing a beta -nucleoside analogue
05/10/2002	WO2001072288A3 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
05/02/2002	WO2001092282A3 Methods and compositions for treating flaviviruses and pestiviruses
04/2002
04/23/2002	US6376657 Pharmaceutical compositions having appetite suppressant activity
04/17/2002	CN1082819C United pharmaceutical system for abrogation of viral resistance to nucleoside analogues by double-stranded RNAS
03/2002
03/28/2002	WO2002024909A2 Receptor nucleic acids and polypeptides
03/20/2002	EP0970074B1 Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration
03/19/2002	CA2055912C Novel erythromycin derivatives, their preparation process, the new intermediated obtained and their application as drugs
03/14/2002	WO2001090124A3 Haplotypes of the gpr31 gene
03/07/2002	US20020028920 Processes for preparing clarithromycin polymorphs
03/06/2002	CN1080263C Method and compositions for the synthesis of dioxolane nucleosides with 'beta'-configuration
02/2002
02/27/2002	EP1181298A1 Novel 8a- and 9a-15-membered lactams
02/20/2002	EP1180110A1 13-methyl-erythromycin derivatives
02/12/2002	US6346613 An antisense oligonucleotide that hybridizes with a occludin mrna and disrupts tight junctions, to increase cell layer permeability to solutes and drugs
01/2002
01/30/2002	EP1175429A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
01/30/2002	EP1175428A1 3-deoxy-desmycosin derivatives and process for their preparation
01/29/2002	US6342497 2″-deoxy hygromycin derivatives
01/16/2002	EP1171448A2 Macrolide antiinfective agents

1 2 3 4 5 6 7 8 9 10 11 12